Study for blood metabolomics of patients after laparoscopic colorectal cancer surgery with Xiangbin prescription
Ontology highlight
ABSTRACT: Interventions: Group 1:Routine therapy plus Xiangbin prescription for patients with colorectal cancer (preoperative + postoperative);Group 2:Routine therapy plus placebo for patients with colorectal cancer (preoperative + postoperative);Healthy person:No Intervention
Primary outcome(s): Small Molecular Metabolomics of Blood
Study Design: Non randomized control
DISEASE(S): Colorectal Cancer
PROVIDER: 2682122 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA